scispace - formally typeset
K

Kunisuke Izawa

Researcher at Ajinomoto

Publications -  139
Citations -  3842

Kunisuke Izawa is an academic researcher from Ajinomoto. The author has contributed to research in topics: Amino acid & Yield (chemistry). The author has an hindex of 21, co-authored 139 publications receiving 2984 citations. Previous affiliations of Kunisuke Izawa include Rega Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

New approaches to the industrial synthesis of HIV protease inhibitors

TL;DR: Three new approaches to the assembly of Amprenavir are discussed, and a synthetic route in which an (S)-tetrahydrofuranyloxy carbonyl is attached to l-phenylalanine appears to be the most promising manufacturing process, in that it offers satisfactory stereoselectivity in fewer steps.
Journal ArticleDOI

Radical deoxygenation and dehalogenation of nucleoside derivatives with hypophosphorous acid and dialkyl phosphites

TL;DR: In this paper, Hypophosphorous acid and dialkyl phosphites are used to reduce O-thiocarbonyl groups or halides at the sugar part of nucleoside derivatives and give the corresponding hydrocarbons in high yield.
Journal ArticleDOI

Small‐Molecule Therapeutics for Ebola Virus (EBOV) Disease Treatment

TL;DR: A review of the recent progress in identification of purely chemical, small-molecule drugs of considerable potential to be used as effective therapeutics for prevention, diagnosis, and treatment of EBOV profiles three compounds – favipiravir, BCX-4430, and brincidofovir – identified by the World Health Organization as high-priority targets.
Journal ArticleDOI

Asymmetric Synthesis of Tailor-Made Amino Acids Using Chiral Ni(II) Complexes of Schiff Bases. An Update of the Recent Literature.

TL;DR: This review article summarizes examples of asymmetric synthesis of tailor-made α-amino acids via the corresponding Ni(II) complexes, reported in the literature over the last four years, with the emphasis given to practicality, scalability, cost-structure and recyclability of the chiral tridentate ligands.